UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Galectin-13/PP-13 expression in term placentas of gestational diabetes mellitus pregnancies

Placenta (Eastbourne), 2015-02, Vol.36 (2), p.191-198

2015

Volltextzugriff (PDF)

Expression and function of galectins in the endometrium and at the human feto-maternal interface

Placenta (Eastbourne), 2013-10, Vol.34 (10), p.863-872

2013

Volltextzugriff (PDF)

Getting too sweet: galectin-1 dysregulation in gestational diabetes mellitus

Molecular human reproduction, 2014-07, Vol.20 (7), p.644-649

2014

Volltextzugriff (PDF)

Synthesis of pigments in a three-stage microreactor pilot plant—an experimental technical report

Chemical engineering journal (1996), 2004-08, Vol.101 (1), p.179-185

2004

Volltextzugriff (PDF)

Galectin 2 expression in placentas of pre-eclamptic patients

Geburtshilfe und Frauenheilkunde, 2015-04, Vol.75 (3)

2015

Volltextzugriff (PDF)

Galectin 2 expression in placentas of pre-eclamptic patients

Geburtshilfe und Frauenheilkunde, 2014-09, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

Expression von Galectin-13/PP-13 in der Plazenta bei Gestationsdiabetes

Geburtshilfe und Frauenheilkunde, 2014, Vol.74 (S 01)

2014

Volltextzugriff (PDF)

Expression von Galectinen in Spontan- und rezidivierenden Abort-Plazenten

Geburtshilfe und Frauenheilkunde, 2013, Vol.73 (5)

2013

Volltextzugriff (PDF)

Pigments with improved properties - microreaction technology as a new approach for synthesis of pigments

Macromolecular symposia., 2002-09, Vol.187 (1), p.631-640

2002

Volltextzugriff (PDF)

20 years of DPP pigments - future perspectives

Macromolecular symposia., 2002-09, Vol.187 (1), p.617-630

2002

Volltextzugriff (PDF)

Galectin 2 expression in placentas of pre-eclamptic patients

Geburtshilfe und Frauenheilkunde, 2015

2015

Volltextzugriff (PDF)

Galectin 2 expression in placentas of pre-eclamptic patients

Geburtshilfe und Frauenheilkunde, 2014

2014

Volltextzugriff (PDF)

Pigments with improved properties: Microreaction technology as a new approach for synthesis of pigments

Die Makromolekulare Chemie. Macromolecular symposia, 2002, p.631-640

2002

Volltextzugriff (PDF)

The ADP-Heptose Biosynthesis Enzyme GmhB is a Conserved Gram-Negative Bacteremia Fitness Factor

Infection and immunity, 2022-07, Vol.90 (7), p.e0022422-e0022422

2022

Volltextzugriff (PDF)

Klebsiella pneumoniae causes bacteremia using factors that mediate tissue-specific fitness and resistance to oxidative stress

PLoS pathogens, 2023-07, Vol.19 (7), p.e1011233-e1011233

2023

Volltextzugriff (PDF)

Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study

International journal of cardiology, 2022-01, Vol.346, p.93-99

2022

Volltextzugriff (PDF)

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

The New England journal of medicine, 2021-12, Vol.385 (23), p.2150-2160

2021

Volltextzugriff (PDF)

Geochemistry and Multiomics Data Differentiate Streams in Pennsylvania Based on Unconventional Oil and Gas Activity

Microbiology spectrum, 2022-10, Vol.10 (5), p.e0077022-e0077022

2022

Volltextzugriff (PDF)

Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection

Nature communications, 2022-08, Vol.13 (1), p.4459-4459, Article 4459

2022

Volltextzugriff (PDF)

Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant

mBio, 2021-03, Vol.12 (2)

2021

Volltextzugriff (PDF)

Measurements of top quark properties with the ATLAS detector

EPJ Web of Conferences, 2015, Vol.95, p.4073-1-04073-12

2015

Volltextzugriff (PDF)

Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

European heart journal, 2024-10, Vol.45 (Supplement_1)

2024

Volltextzugriff (PDF)

Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(37)
Tagungsberichte
(6)

Sprache

Englisch
(38)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Galectin-13/PP-13 expression in term placentas of gestational diabetes mellitus pregnancies

Expression and function of galectins in the endometrium and at the human feto-maternal interface

Getting too sweet: galectin-1 dysregulation in gestational diabetes mellitus

Synthesis of pigments in a three-stage microreactor pilot plant—an experimental technical report

Galectin 2 expression in placentas of pre-eclamptic patients

Galectin 2 expression in placentas of pre-eclamptic patients

Expression von Galectin-13/PP-13 in der Plazenta bei Gestationsdiabetes

Expression von Galectinen in Spontan- und rezidivierenden Abort-Plazenten

Pigments with improved properties - microreaction technology as a new approach for synthesis of pigments

20 years of DPP pigments - future perspectives

Galectin 2 expression in placentas of pre-eclamptic patients

Galectin 2 expression in placentas of pre-eclamptic patients

Pigments with improved properties: Microreaction technology as a new approach for synthesis of pigments

The ADP-Heptose Biosynthesis Enzyme GmhB is a Conserved Gram-Negative Bacteremia Fitness Factor

Klebsiella pneumoniae causes bacteremia using factors that mediate tissue-specific fitness and resistance to oxidative stress

Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study

Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR

Geochemistry and Multiomics Data Differentiate Streams in Pennsylvania Based on Unconventional Oil and Gas Activity

Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection

Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant

Measurements of top quark properties with the ATLAS detector

Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

Two-year effectiveness and safety outcomes in 27,333 edoxaban-treated patients with and without a history of major bleeding from the Global ETNA-AF programme

Baseline demographic and clinical characteristics as predictors of adverse outcomes to improve management of patients with AF receiving edoxaban: a subanalysis of the ETNA-AF registry

Persistence to edoxaban treatment in patients with atrial fibrillation: Analysis from the Global ETNA-AF program

Suchergebnisse filtern